Has the licensing of respiratory quinolones for adults and the 7-valent pneumococcal conjugate vaccine (PCV-7) for children had herd effects with respect to antimicrobial non-susceptibility in invasive Streptococcus pneumoniae?

被引:19
作者
Fenoll, A. [2 ]
Aguilar, L. [1 ]
Granizo, J. J. [3 ]
Gimenez, M. J. [1 ]
Aragoneses-Fenoll, L. [2 ]
Mendez, C. [4 ]
Tarrago, D. [2 ]
机构
[1] Univ Complutense, Sch Med, Dept Microbiol, E-28040 Madrid, Spain
[2] Inst Salud Carlos III, Spanish Natl Reference Pneumococcal Lab, Madrid 28220, Spain
[3] Grana Datos SL, Madrid 28223, Spain
[4] Wyeth Farma SA, Dept Med, Madrid 28700, Spain
关键词
D O I
10.1093/jac/dkn413
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The aim of the study was to analyse the evolution of antibiotic non-susceptibility in Spanish invasive Streptococcus pneumoniae after licensure of respiratory-quinolones for adults and 7-valent pneumococcal conjugate vaccine (PCV-7) for immunization of children. All invasive pneumococci received in the Reference Laboratory (January 2000-August 2007; n = 12 957 isolates) were serotyped, and susceptibility to penicillin/erythromycin/levofloxacin was determined. Antibiotic consumption and PCV-7 doses/year were provided by IMS and the manufacturer, respectively. In 2000-07, PCV-7 distribution (doses/1000 inhabitants <= 59 months age/year) increased from 0.0 to 411.90, and antibiotic consumption (DDD/1000 inhabitants/day) was maintained for beta-lactams (approximate to 16), decreased for macrolides (from 4.4 to 2.7) and increased for respiratory fluoroquinolones (from 0.3 to 2.7). The increase in PCV-7 distribution correlated with a decrease in PCV-7 serotypes prevalence among invasive isolates in children (r = -0.976; P < 0.001) and adults (r = -0.905; P = 0.002). This decrease in PCV-7 serotypes correlated with a decrease in penicillin non-susceptibility in children (r = 0.929; P < 0.001) and adults (r = 0.905; P = 0.002) and with erythromycin non-susceptibility in children (r = 0.833; P = 0.010). Penicillin/erythromycin non-susceptibility in 2000 was significantly higher in paediatric versus adult isolates (penicillin: 51.4% versus 29.2%; erythromycin: 39.5% versus 20.4%), but similar in 2006-07 (20% to 24%). The increase in respiratory quinolones consumption correlated with the increase in levofloxacin non-susceptibility in adults (r = 0.926; P = 0.008) but not in children, with different non-susceptibility rates in 2007 (1.6% versus 0.0%; P = 0.013). This ecological analysis suggests that PCV-7 vaccination in children had a herd effect in adults, but consumption of respiratory quinolones in adults had no effect on pneumococcal susceptibility to levofloxacin in children. Penicillin/erythromycin non-susceptibility decreased along the studied period among paediatric invasive S. pneumoniae isolates to a level similar to that seen in adults.
引用
收藏
页码:1430 / 1433
页数:4
相关论文
共 18 条
[1]  
[Anonymous], 1999, WKLY EPIDEMIOL REC
[2]   Reduction in pediatric invasive pneumococcal disease in the Basque Country and Navarre, Spain, after introduction of the heptavalent pneumococcal conjugate vaccine [J].
Aristegui, J. ;
Bernaola, E. ;
Pocheville, I. ;
Garcia, C. ;
Arranz, L. ;
Duran, G. ;
Perez, L. ;
Bastida, M. ;
Canduela, C. ;
Aguirre, M. Herranz ;
Garrote, E. ;
Fletcher, M. A. ;
Perez, C. .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2007, 26 (05) :303-310
[3]   Effectiveness of the 7-valent pneumococcal conjugate vaccine: A population-based case-control study [J].
Barricarte, Aurelio ;
Castilla, Jesus ;
Gil-Setas, Alberto ;
Torroba, Luis ;
Navarro-Alonso, Jose Antonio ;
Irisarri, Fatima ;
Arriazu, Maite .
CLINICAL INFECTIOUS DISEASES, 2007, 44 (11) :1436-1441
[4]   Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente [J].
Black, S ;
Shinefield, H ;
Baxter, R ;
Austrian, R ;
Bracken, L ;
Hansen, J ;
Lewis, E ;
Fireman, B .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2004, 23 (06) :485-489
[5]   Invasive pneumococcal disease among children in a health district of Barcelona:: early impact of pneumococcal conjugate vaccine [J].
Calbo, E. ;
Diaz, A. ;
Canadell, E. ;
Fabrega, J. ;
Uriz, S. ;
Xercavins, M. ;
Morera, M. A. ;
Cuchi, E. ;
Rodriguez-Carballeira, M. ;
Garau, J. .
CLINICAL MICROBIOLOGY AND INFECTION, 2006, 12 (09) :867-872
[6]  
Clinical and Laboratory Standards Institute, 2008, M100S18 CLSI
[7]  
Clinical and Laboratory Standards Institute, 2006, M7A7 CLSI
[8]   Dot blot assay for the serotyping of pneumococci [J].
Fenoll, A ;
Jado, I ;
Vicioso, D ;
Casal, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (03) :764-766
[9]   Antimicrobial susceptibility and pneumococcal serotypes [J].
Fenoll, A ;
Asensio, G ;
Jado, I ;
Berrón, S ;
Camacho, MT ;
Ortega, M ;
Casal, J .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 :13-19
[10]  
FENOLL A, 1991, REV INFECT DIS, V13, P56